Safeguard Investment Advisory Group’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-25
Closed -$6K 145
2020
Q4
$6K Buy
+25
New +$6.45K 0.01% 488

Other funds holding BIIB

Safeguard Investment Advisory Group's BIIB Position: Q1 2021 in Review

Safeguard Investment Advisory Group sold out of Biogen (BIIB) in Q1 2021, closing a stake of 25 shares — an estimated $6K sold.

Safeguard Investment Advisory Group first reported a position in BIIB in Q4 2020 and held it in 1 quarter. The position peaked at $6K in Q4 2020. 1,093 funds tracked by Wall St. Rank hold BIIB as of Q1 2021.

  • Safeguard Investment Advisory Group reported no remaining Biogen position as of Q1 2021 after selling out during the quarter.
  • Safeguard Investment Advisory Group sold 25 Biogen shares in Q1 2021, an estimated $6K.
  • Safeguard Investment Advisory Group first reported a position in Biogen in Q4 2020 and held it in 1 quarter.
  • Safeguard Investment Advisory Group's Biogen position peaked at $6K in Q4 2020.
  • 1,093 funds tracked by Wall St. Rank held Biogen as of Q1 2021.

Based on Safeguard Investment Advisory Group's 13F filing for Q1 2021, filed 10 May 2021.